Contact Information: FOR FURTHER INFORMATION, CONTACT: Michael Brennan Chairman Micro Imaging Technology, Inc. Email: Email Contact Phone: (805) 557-0614
Micro Imaging Technology Announces Orders From Yotsubishi Corporation
| Source: Micro Imaging Technology, Inc.
SAN CLEMENTE, CA -- (MARKET WIRE) -- March 6, 2007 --Micro Imaging Technology, Inc. (OTCBB : MMTC )
announced that it has received initial orders for MIT's systems for rapid
microbial identification from Yotsubishi Corporation. Michael Brennan,
MIT's Chairman, stated that "It is an honor to be chosen as a system
supplier for Yotsubishi Corporation -- whose core competence is providing
environmental sampling and monitoring instrumentation. Significant market
penetration is expected by coupling MIT's systems that are capable of
detecting pathogens simply and within minutes with the proven strength of
Yotsubishi's marketing and support resources. The Yotsubishi orders come
after MIT's recent announcement on January 7, 2007, of an OEM Supply
Agreement from San Diego-based JMAR Corporation -- these orders are
starting MIT's year off on a very positive note."
About Yotsubishi Corporation:
Yotsubishi Corporation is a SIBATA SCIENTIFIC TECHNOLOGY Ltd. Group company
responsible for all export businesses and global expansion. SIBATA was
founded in 1921 as a laboratory glassware manufacturer and has successfully
expanded as a leading innovator in the medical, chemical and
environmental-measuring field in Japan. Through the years, SIBATA has
developed and modified various technologies including Beta-ray attenuation,
light-scattering, pressure-resistant sampling pumps for environmental
testing and measuring methods that are in use worldwide. Yotsubishi is
located in Chiyoda-ku Tokyo 101-0053, Japan and can be reached at e-mail:
sales@yotsubishi.com
About Micro Imaging Technology:
MIT has developed and patented a laser-based technology for rapid microbe
detection and identification. The system measures scattered light intensity
as individual microbes pass through a laser beam. The intensity pattern of
the scattered light is a direct consequence of the size, shape and external
and internal optical characteristics of the microbe. The MIT System is
non-biological and does not rely on biological agents, conventional
chemical processing, fluorescent tags, gas chromatography or DNA analysis.
MIT has demonstrated the ability to detect and identify, within minutes,
the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus,
Shigella and other pathogenic bacteria and protozoa; including
Cryptosporidium and Giardia. The identification process has been tested and
verified by North American Science Associates, Inc. (NAMSA), an independent
and internationally recognized testing and certification laboratory. The
NAMSA Test Report, available from the Company, confirms the accuracy, speed
and efficiency of the MIT system over conventional processes.
This release contains statements that are forward looking in nature.
Statements that are predictive in nature, that depend upon or refer to
future events or conditions or that include words such as "expects,"
"anticipates," "intends," "plans," "believes," "estimates," and similar
expressions are forward-looking statements. These statements are made
based upon information available to the Company as of the date of this
release, and we assume no obligation to update any such forward-looking
statements. These statements are not guarantees of future performance and
actual results could differ materially from our current expectations.
Factors that could cause or contribute to such differences include, but are
not limited to dependence on suppliers; short product life cycles and
reductions in unit selling prices; delays in development or shipment of new
products; lack of market acceptance of our new products or services;
inability to continue to develop competitive new products and services on a
timely basis; introduction of new products or services by major
competitors; our ability to attract and retain qualified employees;
inability to expand our operations to support increased growth; and
declining economic conditions, including a recession. These and other
factors and risks associated with our business are discussed from time to
time within our filings with the Securities and Exchange Commission.